Selected research
Market Structure
Global Recombinant Protein Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Recombinant Protein Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Recombinant Protein Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Recombinant Protein Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Recombinant Protein Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Recombinant Protein Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Recombinant Protein Service include Sino Biological, Boster Bio, Proteos, ImmunoDiagnostics Limited, BiologicsCorp, GenScript, OriGene Technologies, R＆D Systems and Biomiga, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Recombinant Protein Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Recombinant Protein Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Recombinant Protein Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Recombinant Protein Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Recombinant Protein Service Segment by Company
Sino Biological
Boster Bio
Proteos
ImmunoDiagnostics Limited
BiologicsCorp
GenScript
OriGene Technologies
R＆D Systems
Biomiga
Genemed
RayBiotech
BioServUK
Elabscienc
Jubilant Biosys
Recombinant Protein Service Segment by Type
Protein Purification
Protein Expression
Protein Modification And Processing
Other
Recombinant Protein Service Segment by Application
Antibody Production
Vaccine Production
Protein Pharmaceutical Production
Other
Recombinant Protein Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Protein Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Recombinant Protein Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Protein Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Recombinant Protein Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Recombinant Protein Service industry.
Chapter 3: Detailed analysis of Recombinant Protein Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Protein Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Protein Purification
- Protein Expression
- Protein Modification And Processing
- Other
Applications
- Antibody Production
- Vaccine Production
- Protein Pharmaceutical Production
- Other
Companies covered
- Sino Biological
- Boster Bio
- Proteos
- ImmunoDiagnostics Limited
- BiologicsCorp
- GenScript
- OriGene Technologies
- R＆D Systems
- Biomiga
- Genemed
- RayBiotech
- BioServUK
- Elabscienc
- Jubilant Biosys
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Recombinant Protein Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Protein Purification
- 1.2.3 Protein Expression
- 1.2.4 Protein Modification And Processing
- 1.2.5 Other
- 1.3 Market Analysis by Application
- 1.3.1 Global Recombinant Protein Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Antibody Production
- 1.3.3 Vaccine Production
- 1.3.4 Protein Pharmaceutical Production
- 1.3.5 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Recombinant Protein Service Growth Trends by Region
- 1.5.1 Global Recombinant Protein Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Recombinant Protein Service Market Size by Region (2021-2026)
- 1.5.3 Recombinant Protein Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Recombinant Protein Service Market Dynamics
- 2.1 Recombinant Protein Service Industry Trends
- 2.2 Recombinant Protein Service Industry Drivers
- 2.3 Recombinant Protein Service Industry Opportunities and Challenges
- 2.4 Recombinant Protein Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Recombinant Protein Service Revenue by Company (2021-2026)
- 3.2 Global Recombinant Protein Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Recombinant Protein Service Key Company Head office and Area Served
- 3.4 Global Recombinant Protein Service Company, Product Type & Application
- 3.5 Global Recombinant Protein Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Recombinant Protein Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Recombinant Protein Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Recombinant Protein Service Tier 1, Tier 2, and Tier 3
4 Recombinant Protein Service Market by Type
- 4.1 Global Recombinant Protein Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Recombinant Protein Service Market Size by Type (2021-2032)
- 4.3 Global Recombinant Protein Service Market Size Share by Type (2021-2032)
5 Recombinant Protein Service Market by Application
- 5.1 Global Recombinant Protein Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Recombinant Protein Service Market Size by Application (2021-2032)
- 5.3 Global Recombinant Protein Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Sino Biological
- 6.1.1 Sino Biological Company Information
- 6.1.2 Sino Biological Business Overview
- 6.1.3 Sino Biological Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Sino Biological Recombinant Protein Service Product Portfolio
- 6.1.5 Sino Biological Recent Developments
- 6.2 Boster Bio
- 6.2.1 Boster Bio Company Information
- 6.2.2 Boster Bio Business Overview
- 6.2.3 Boster Bio Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Boster Bio Recombinant Protein Service Product Portfolio
- 6.2.5 Boster Bio Recent Developments
- 6.3 Proteos
- 6.3.1 Proteos Company Information
- 6.3.2 Proteos Business Overview
- 6.3.3 Proteos Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Proteos Recombinant Protein Service Product Portfolio
- 6.3.5 Proteos Recent Developments
- 6.4 ImmunoDiagnostics Limited
- 6.4.1 ImmunoDiagnostics Limited Company Information
- 6.4.2 ImmunoDiagnostics Limited Business Overview
- 6.4.3 ImmunoDiagnostics Limited Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 ImmunoDiagnostics Limited Recombinant Protein Service Product Portfolio
- 6.4.5 ImmunoDiagnostics Limited Recent Developments
- 6.5 BiologicsCorp
- 6.5.1 BiologicsCorp Company Information
- 6.5.2 BiologicsCorp Business Overview
- 6.5.3 BiologicsCorp Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 BiologicsCorp Recombinant Protein Service Product Portfolio
- 6.5.5 BiologicsCorp Recent Developments
- 6.6 GenScript
- 6.6.1 GenScript Company Information
- 6.6.2 GenScript Business Overview
- 6.6.3 GenScript Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 GenScript Recombinant Protein Service Product Portfolio
- 6.6.5 GenScript Recent Developments
- 6.7 OriGene Technologies
- 6.7.1 OriGene Technologies Company Information
- 6.7.2 OriGene Technologies Business Overview
- 6.7.3 OriGene Technologies Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 OriGene Technologies Recombinant Protein Service Product Portfolio
- 6.7.5 OriGene Technologies Recent Developments
- 6.8 R＆D Systems
- 6.8.1 R＆D Systems Company Information
- 6.8.2 R＆D Systems Business Overview
- 6.8.3 R＆D Systems Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 R＆D Systems Recombinant Protein Service Product Portfolio
- 6.8.5 R＆D Systems Recent Developments
- 6.9 Biomiga
- 6.9.1 Biomiga Company Information
- 6.9.2 Biomiga Business Overview
- 6.9.3 Biomiga Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Biomiga Recombinant Protein Service Product Portfolio
- 6.9.5 Biomiga Recent Developments
- 6.10 Genemed
- 6.10.1 Genemed Company Information
- 6.10.2 Genemed Business Overview
- 6.10.3 Genemed Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Genemed Recombinant Protein Service Product Portfolio
- 6.10.5 Genemed Recent Developments
- 6.11 RayBiotech
- 6.11.1 RayBiotech Company Information
- 6.11.2 RayBiotech Business Overview
- 6.11.3 RayBiotech Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 RayBiotech Recombinant Protein Service Product Portfolio
- 6.11.5 RayBiotech Recent Developments
- 6.12 BioServUK
- 6.12.1 BioServUK Company Information
- 6.12.2 BioServUK Business Overview
- 6.12.3 BioServUK Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 BioServUK Recombinant Protein Service Product Portfolio
- 6.12.5 BioServUK Recent Developments
- 6.13 Elabscienc
- 6.13.1 Elabscienc Company Information
- 6.13.2 Elabscienc Business Overview
- 6.13.3 Elabscienc Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Elabscienc Recombinant Protein Service Product Portfolio
- 6.13.5 Elabscienc Recent Developments
- 6.14 Jubilant Biosys
- 6.14.1 Jubilant Biosys Company Information
- 6.14.2 Jubilant Biosys Business Overview
- 6.14.3 Jubilant Biosys Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Jubilant Biosys Recombinant Protein Service Product Portfolio
- 6.14.5 Jubilant Biosys Recent Developments
7 North America
- 7.1 North America Recombinant Protein Service Market Size (2021-2032)
- 7.2 North America Recombinant Protein Service Market Size by Type
- 7.2.1 North America Recombinant Protein Service Market Size by Type (2021-2026)
- 7.2.2 North America Recombinant Protein Service Market Size by Type (2027-2032)
- 7.2.3 North America Recombinant Protein Service Market Share by Type (2021-2032)
- 7.3 North America Recombinant Protein Service Market Size by Application
- 7.3.1 North America Recombinant Protein Service Market Size by Application (2021-2026)
- 7.3.2 North America Recombinant Protein Service Market Size by Application (2027-2032)
- 7.3.3 North America Recombinant Protein Service Market Share by Application (2021-2032)
- 7.4 North America Recombinant Protein Service Market Size by Country
- 7.4.1 North America Recombinant Protein Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Recombinant Protein Service Market Size by Country (2021-2026)
- 7.4.3 North America Recombinant Protein Service Market Size by Country (2027-2032)
- 7.4.4 North America Recombinant Protein Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Recombinant Protein Service Market Size (2021-2032)
- 8.2 Europe Recombinant Protein Service Market Size by Type
- 8.2.1 Europe Recombinant Protein Service Market Size by Type (2021-2026)
- 8.2.2 Europe Recombinant Protein Service Market Size by Type (2027-2032)
- 8.2.3 Europe Recombinant Protein Service Market Share by Type (2021-2032)
- 8.3 Europe Recombinant Protein Service Market Size by Application
- 8.3.1 Europe Recombinant Protein Service Market Size by Application (2021-2026)
- 8.3.2 Europe Recombinant Protein Service Market Size by Application (2027-2032)
- 8.3.3 Europe Recombinant Protein Service Market Share by Application (2021-2032)
- 8.4 Europe Recombinant Protein Service Market Size by Country
- 8.4.1 Europe Recombinant Protein Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Recombinant Protein Service Market Size by Country (2021-2026)
- 8.4.3 Europe Recombinant Protein Service Market Size by Country (2027-2032)
- 8.4.4 Europe Recombinant Protein Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Recombinant Protein Service Market Size (2021-2032)
- 9.2 China Recombinant Protein Service Market Size by Type
- 9.2.1 China Recombinant Protein Service Market Size by Type (2021-2026)
- 9.2.2 China Recombinant Protein Service Market Size by Type (2027-2032)
- 9.2.3 China Recombinant Protein Service Market Share by Type (2021-2032)
- 9.3 China Recombinant Protein Service Market Size by Application
- 9.3.1 China Recombinant Protein Service Market Size by Application (2021-2026)
- 9.3.2 China Recombinant Protein Service Market Size by Application (2027-2032)
- 9.3.3 China Recombinant Protein Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Recombinant Protein Service Market Size (2021-2032)
- 10.2 Asia Recombinant Protein Service Market Size by Type
- 10.2.1 Asia Recombinant Protein Service Market Size by Type (2021-2026)
- 10.2.2 Asia Recombinant Protein Service Market Size by Type (2027-2032)
- 10.2.3 Asia Recombinant Protein Service Market Share by Type (2021-2032)
- 10.3 Asia Recombinant Protein Service Market Size by Application
- 10.3.1 Asia Recombinant Protein Service Market Size by Application (2021-2026)
- 10.3.2 Asia Recombinant Protein Service Market Size by Application (2027-2032)
- 10.3.3 Asia Recombinant Protein Service Market Share by Application (2021-2032)
- 10.4 Asia Recombinant Protein Service Market Size by Country
- 10.4.1 Asia Recombinant Protein Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Recombinant Protein Service Market Size by Country (2021-2026)
- 10.4.3 Asia Recombinant Protein Service Market Size by Country (2027-2032)
- 10.4.4 Asia Recombinant Protein Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Recombinant Protein Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Recombinant Protein Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Recombinant Protein Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Recombinant Protein Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Recombinant Protein Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Recombinant Protein Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Recombinant Protein Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Recombinant Protein Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Recombinant Protein Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Recombinant Protein Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Recombinant Protein Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Recombinant Protein Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Recombinant Protein Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Recombinant Protein Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst